Evidence mapPaperPMID 23209641Full record

ArticlePloS one2012

The activities of lysyl hydroxylase 3 (LH3) regulate the amount and oligomerization status of adiponectin.

Heli Ruotsalainen, Maija Risteli, Chunguang Wang, Yu Wang, Marjo Karppinen, Ulrich Bergmann, Ari-Pekka Kvist, Helmut Pospiech, Karl-Heinz Herzig, Raili Myllylä

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Targeting collagen to optimize cancer immunotherapy.Experimental hematology & oncology · 2025
    Review
  2. Article
  3. Journal of microbiology and biotechnology · 2024
    Article
  4. Collagen beta (1-Bioscience reports · 2017
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Heli RuotsalainenDepartment of Biochemistry, University of Oulu, Oulu, Finland. heli.ruotsalainen@oulu.fi
Maija Risteli
Chunguang Wang
Yu Wang
Marjo Karppinen
Ulrich Bergmann
Ari-Pekka Kvist
Helmut Pospiech
Karl-Heinz Herzig
Raili Myllylä
Oulu University of Applied Sciences · FIUniversity of Oulu · FIBiocenter Finland · FIUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lysyl hydroxylase 3 (LH3) has lysyl hydroxylase, galactosyltransferase, and glucosyltransferase activities, which are sequentially required for the formation of glucosylgalactosyl hydroxylysines in collagens. Here we demonstrate for the first time that LH3 also modifies the lysine residues in the collagenous domain of adiponectin, which has important roles in glucose and lipid metabolism and inflammation. Hydroxylation and, especially, glycosylation of the lysine residues of adiponectin have been shown to be essential for the formation of the more active high molecular weight adiponectin oligomers and thus for its function. In cells that totally lack LH3 enzyme, the galactosylhydroxylysine residues of adiponectin were not glucosylated to glucosylgalactosylhydroxylysine residues and the formation of high and middle molecular weight adiponectin oligomers was impaired. Circulating adiponectin levels in mutant mice lacking the lysyl hydroxylase activity of LH3 were significantly reduced, which indicates that LH3 is required for complete modification of lysine residues in adiponectin and the loss of some of the glycosylated hydroxylysine residues severely affects the secretion of adiponectin. LH mutant mice with reduced adiponectin level showed a high fat diet-induced increase in glucose, triglyceride, and LDL-cholesterol levels, hallmarks of the metabolic syndrome in humans. Our results reveal the first indication that LH3 is an important regulator of adiponectin biosynthesis, secretion and activity and thus might be a potential candidate for therapeutic applications in diseases associated with obesity and insulin resistance.

Indexed as

Protein MultimerizationAdiponectinAmino Acid SequenceAnimalsCell LineEnzyme ActivationFemaleGene Expression RegulationGene Knockout TechniquesGenotypeGlycosylationHydroxylationLysineMaleMiceMolecular Sequence DataAdiponectinLysinelysyl hydroxylase 3, mouseProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseRecombinant Proteins

Identifiers

PMID23209641
PMCPMC3510199
OpenAlexW1979738231

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.